Resources

Upcoming Events:

Society of Toxicology (SOT) 2026

March 22-25, 2026 | San Diego, California

Booth: 2211

The Society of Toxicology (SOT) Annual Meeting is the leading global forum for advancing toxicological science, bringing together experts from academia, industry, and government to share emerging research and address evolving regulatory and safety challenges.

At LifeNet Health LifeSciences, we support this progress through innovative New Approach Methodologies (NAMs) designed to better reflect human biology across discovery and safety assessment. From high-quality, prospectively recovered human biospecimens to advanced in vitro models and integrated multi-organ microphysiological systems (MPS), our solutions generate predictive, human-relevant data that strengthens safety evaluation and risk assessment.

See What We’re Showcasing at SOT

Primary human lung cells to aid and accelerate efforts in COVID-19

LifeNet Health LifeSciences has isolated primary human lung cells to aid and accelerate efforts in COVID-19 drug development

February 3, 2021

VIRGINIA BEACH, Va. (Feb. 3, 2021) — LifeNet Health LifeSciences has successfully isolated three types of primary human lung epithelial cells from a single donor. One of the three types, alveolar epithelial type II cells, are of particular interest to scientists due to their applicability for respiratory disease research. LifeNet Health’s scientists have also isolated the bronchial and small airway epithelial cells, which are critical for the first lines of defense in protecting the lungs.

LifeNet Health launches newly expanded LifeSciences division

LifeNet Health launches newly expanded LifeSciences division with innovative solutions for researchers

January 13, 2021

VIRGINIA BEACH, Va. — LifeNet Health announced today the launch of their newly expanded LifeSciences division which is offering human cell- and tissue-based research solutions through a new website, LNHLifeSciences.org.

LifeNet Health expands primary human liver cell offering

LifeNet Health strengthens its LifeSciences Division with Samsara Sciences asset acquisition

November 07, 2019

Virginia Beach, VA. - LifeNet Health, the world's leading provider of regenerative medicine solutions, has acquired the assets of Samsara Sciences, a San Diego-based life sciences company specializing in human primary liver and kidney cell isolation. The acquisition includes Samsara's equipment, inventory and associated technology.

New Center of Excellence for research in San Diego

LifeNet Health unveils Center of Excellence for research in San Diego

May 14, 2019

SAN DIEGO, Calif. - May 14, 2019 - LifeNet Health, the world’s leading provider of regenerative medicine solutions, today announced the opening of a San Diego facility that stands as a Center of Excellence for its life sciences and tissue-engineering programs, as well as a logistical hub for hospital and surgeon clients on the West Coast.

LifeNet Health expands regenerative medicine efforts with opening of Research Triangle Park, N.C., facility

November 03, 2016

Virginia Beach, Va. — Nov. 2, 2016 — LifeNet Health is expanding its cell-based research and processing capacity with the opening of a facility in North Carolina’s Research Triangle Park (RTP), near Durham. It will be an extension of its flagship research center, the LifeNet Health Institute of Regenerative Medicine, located at the company’s headquarters in Virginia Beach, Va.

LifeNet Health announces new advances technology platforms with acquisition of Vivo Biosciences, Inc., assets

November 2, 2016

Virginia Beach, Va. — Nov. 2, 2016 — LifeNet Health has acquired the assets of Alabama-based biotechnology company Vivo Biosciences, Inc., as part of the organization’s growing emphasis on applying cell-based innovations to the process of pharmaceutical discovery and personalized medicine.